An 11-Gene Signature Based on Treatment Responsiveness Predicts Radiation Therapy Survival Benefit Among Breast Cancer Patients

PURPOSE: We developed a strategy of building prognosis gene signature based on clinical treatment responsiveness to predict radiotherapy survival benefit in breast cancer patients. METHODS AND MATERIALS: Analyzed data came from the public database. PFS was used as an indicator of clinical treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Junjie, Yan, Derui, Bai, Lu, Geng, Ruirui, Zhao, Xulun, Li, Huijun, Dong, Yongfei, Cao, Jianping, Tang, Zaixiang, Liu, Song-bai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770413/
https://www.ncbi.nlm.nih.gov/pubmed/35071020
http://dx.doi.org/10.3389/fonc.2021.816053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770413/
https://www.ncbi.nlm.nih.gov/pubmed/35071020
http://dx.doi.org/10.3389/fonc.2021.816053

Ejemplares similares